News | March 14, 2011

Michigan Hospital Performs Robotic Heart Procedure for Atrial Fibrillation

March 14, 2011 – Doctors at Beaumont Hospital in Troy, Mich., have performed the state’s first minimally invasive robotic procedure to correct atrial fibrillation. The new robotic maze procedure is an alternative to open-heart surgery. It's performed through tiny, keyhole incisions with fewer complications and a shorter hospital stay.

Phillip Robinson, M.D., cardiovascular surgeon, Brian Williamson, M.D. and Ilana Kutinsky, D.O., both electrophysiology cardiologists, performed the robotic-assisted maze procedure on March 2 on a 66-year-old woman. The robotic approach allows for smaller incisions and greater precision.

A maze procedure is a surgical treatment for atrial fibrillation that is used to stop an irregular heartbeat and restore a normal heart rhythm. Patients are candidates for a maze procedure if their irregular heartbeat cannot be treated with medication or other nonsurgical approaches.

"This new robotic maze procedure allows us to correct an electrical irregularity in the heart without having to perform open-heart surgery," Robinson said. "We don't have to open the patient's chest, stop the heart or place the patient on a heart-lung machine. As a result, patients have fewer complications, less risk of infection, a shorter hospital stay and a quicker recovery."

With the procedure, the surgeon makes five tiny incisions the size of a dime in the patient's chest, inserting a small endoscopic robotic camera to view the outer surface of the heart. The surgeon sits at a console viewing 3-D images from the robotic camera, while directing robotic arms with their attached surgical instruments. A device is then passed through the tiny incisions to ablate or destroy areas of heart tissue, creating a scar that will block the conduction of abnormal electrical impulses and create a pathway, or maze, for normal electrical signals to travel to the heart's lower chambers (ventricles).

"This procedure combines the specialized skills and expertise of a cardiovascular surgeon and an electrophysiology cardiologist to provide a new treatment option benefiting AF patients," Kutinsky said.

The procedure takes approximately two to three hours. Most patients are able to go home within two to three days after the procedure.

Candidates include those who cannot tolerate drugs, such as blood thinners; patients whose quality of life is limited by drugs; those who continue to slip into an irregular heart rhythm; and those who cannot have catheter ablation or have had it, but still have AF symptoms.

Atrial fibrillation is an irregular rhythm of the heart's upper chambers (atria) causing the heart to quiver in a fast, uncontrolled manner. As a result, blood is not pumped completely out of the atria and may pool or clot. If a blood clot leaves the heart and becomes lodged in an artery in the brain, a stroke may occur. About 15 percent of strokes occur in people with atrial fibrillation.

For most people with atrial fibrillation, slowing heart rate with medications is the most appropriate treatment. AF patients can also be treated with electrical cardioversion (restoring heart rhythm with an electrical shock); radiofrequency ablation (destroying heart tissue with radiofrequency energy); or through traditional open-heart maze surgery. Patients with atrial fibrillation should also take blood thinners to prevent stroke, unless they have a condition that would make use of blood thinners dangerous.

For more information: www.heart.beaumonthospitals.com

Related Content

Medtronic Cryoballoon Improves Quality of Life, Reduces Systems of Persistent Atrial Fibrillation
News | Ablation Systems | August 28, 2018
Medtronic plc announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life...
Thermedical Announces FDA IDE Approval for Clinical Study of Durablate Catheter
News | Ablation Systems | August 02, 2018
Thermedical announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device...
Boston Scientific to Acquire Cryterion Medical Inc.
News | Ablation Systems | July 13, 2018
Boston Scientific Corp. recently announced a definitive agreement to acquire Cryterion Medical Inc., a privately-held...
Treating AFib With Ablation Reduces Mortality and Stroke
News | Ablation Systems | July 05, 2018
Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the...
LuxCath Showcases OmniView Light-Guided Ablation Catheter at HRS 2018
News | Ablation Systems | May 22, 2018
LuxCath LLC showcased the next generation of its proprietary OmniView light-guided catheter ablation system at the 2018...
The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously.  #HRS2018

The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously. 

News | Ablation Systems | May 21, 2018
May 21, 2018 — Complete pulmonary vein isolation (PVI) was achieved in more than 99 percent of patients in a first-in
CardioFocus Announces Successful Live Case Featuring HeartLight X3 System
News | Ablation Systems | May 17, 2018
Medical device manufacturer CardioFocus Inc. announced a successful live case featuring its HeartLight X3 System during...
Imricor MRI-Guided Cardiac Ablation Study Results to Be Presented at HRS 2018
News | Ablation Systems | May 10, 2018
Results from the clinical study to evaluate Imricor’s Vision-MR Ablation Catheter for the treatment of atrial flutter...
Biosense Webster Launches Carto Vizigo Bi-Directional Guidance Sheath
Technology | Ablation Systems | May 08, 2018
Biosense Webster Inc. announced its Carto Vizigo Bi-directional Guiding Sheath is now available in the United States....
Stereotaxis and Acutus Medical Announce Strategic Collaboration
News | Ablation Systems | May 04, 2018
Stereotaxis and Acutus Medical announced a strategic collaboration to integrate the Stereotaxis Niobe Magnetic...
Overlay Init